Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

Study Status Table

 

Studies & Sites Table

 

Studies by Country

 

Studies by Research Area

 

Study Phase Definitions


Study Phase Definitions

Phase I Trials - Safety. The first time an experimental drug will be used in humans. The purpose of a Phase I trial is to assess the initial safety of the drug, as well as the metabolism, absorption, elimination and other drug activities, the preferred mode of drug administration (topical, IV, oral, etc.) and safe drug range. Usually trials are conducted on healthy volunteers. 

Phase II Trials - Dosage. The purpose is to explore the effectiveness of different dosage schedules for a research treatment following safety evaluation in a Phase I trial. Trials are usually conducted on patients. 

Phase III Trials - Efficacy. The purpose of a Phase III trial is to assess a drug's effectiveness (efficacy) and safety compared against a suitable placebo or best current treatment or to determine the optimum dosage level for the treatment of a specific condition in a specific group of patients. These studies are randomized, intervention allocation and measurement is usually masked form study participants and investigators.  

Other Trials - Any prospective comparative study involving human participants and the administration of a treatment or type of management, including diagnosis or the provision of lifestyle (e.g. dietary) advice.

      
 

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: June 07, 2007